Since we observed increased phosphorylation of GSK3β at position Ser9, this, as well as the phosphorylation of Akt and mTOR already discussed, suggests an escape mechanism of the treated GBM cells, which ultimately promotes tumor cell survival even upon TMZ+AT101/AT101 therapy. The gene discussed is MTOR; the disease is glioblastoma.